Insights from Digital Pharma Leaders
Refine search
Pharmaceutical
US analytics specialist Phesi has called for a major rethink in how oncology trials are planned and run, saying clinical development has failed to keep pace with scientific progress. 15 May 2025
Pharmaceutical
This week on The Pharma Letter Podcast, we are joined by Tony Clarke, senior VP of IT digital operations at ICON. 8 May 2025
Pharmaceutical
US investment firm Deerfield Management has closed its latest fund with $600 million in commitments to support advances in drug development, healthcare delivery, and AI-powered technologies. 6 May 2025
Pharmaceutical
Japanese biotech Prism BioLab has entered a strategic partnership with AI drug discovery company Elix to accelerate the development of small molecule therapies for difficult-to-treat diseases. 14 April 2025
Biotechnology
MeiraGTx has entered into a strategic partnership with artificial intelligence firm Hologen to accelerate the Phase III development of AAV-GAD, a gene therapy for Parkinson’s disease. 6 April 2025
Pharmaceutical
Precision medicine has advanced significantly over the past decade, driven by breakthroughs in chemical, hardware, software, and especially cloud computing technologies. 4 April 2025
Pharmaceutical
A newly-published randomized controlled trial (RCT) has demonstrated that Deprexis, a digital therapeutic for depression with already extensive clinical validation, shows enhanced effectiveness when used alongside transcranial infrared laser stimulation (TILS). 25 March 2025
Pharmaceutical
Insilico Medicine has raised $110 million in a series E funding round to drive the development of its artificial intelligence-powered drug candidates, including its leading drug for idiopathic pulmonary fibrosis (IPF). 13 March 2025
Pharmaceutical
Germany’s Boehringer Ingelheim has launched the One Medicine Platform, a new system designed to streamline drug development, following the implementation of Veeva Systems' Development Cloud. 12 March 2025
Biotechnology
Nona Biosciences has introduced Hu-mAtrIx, an AI-assisted drug discovery platform designed to accelerate the identification and development of antibody-based therapies. 7 March 2025
Pharmaceutical
The new US President has repealed an executive order from October 2023, signed by the Biden administration, that sought to establish rigorous safeguards for artificial intelligence (AI) development. 22 February 2025
Pharmaceutical
US biopharma Incyte and privately-held AI-focused biotech Genesis Therapeutics have entered into a strategic collaboration focused on the research, discovery and development of novel small molecule medicines. 21 February 2025
Pharmaceutical
An Expert View from Kevin Wild, head of pre-sales at software company Syniti. 23 January 2025
Pharmaceutical
French pharmaceutical company Servier and Google Cloud have announced an expanded five-year partnership aimed at leveraging artificial intelligence (AI) and generative AI to accelerate drug research and development. 16 January 2025
Pharmaceutical
A collection of some of the largest US health systems, in collaboration with the Regeneron Genetics Center, have announced the launch of the Truveta Genome Project. 16 January 2025
Pharmaceutical
Privately-held Italian drugmaker Menarini and its oncology-focused subsidiary Stemline Therapeutics have entered into a licensing deal with AI-driven biotech Insilico Medicines. 15 January 2025
Biotechnology
Dyno Therapeutics, a privately-held US genetic technologies company applying AI to enable in vivo gene delivery, has announced that Roche has exercised its option to license a novel capsid for use in a gene therapy program for an undisclosed neurological disease indication. 13 January 2025
Pharmaceutical
Real-world evidence (RWE) specialist Atropos Health has announced a collaboration with US pharma giant Merck & Co. 13 January 2025
Biotechnology
Belgian biopharmaceutical company UCB has entered into a license agreement with Ailux Biologics, the biologics discovery division of XtalPi, to leverage its AI platform. 9 January 2025
Pharmaceutical
Insilico Medicine, a biotechnology firm specializing in artificial intelligence-powered drug discovery, has raised over $100 million in a series E funding round. 8 January 2025
Pharmaceutical
Incyte and Edison Scientific have announced a strategic collaboration to employ Kosmos, Edison’s AI scientist, for the US biopharma’s discovery and development work. 20 May 2026
Pharmaceutical
Chicago, USA-based artificial intelligence company Tempus AI announced a new initiative with US pharma major Bristol Myers Squibb. 15 May 2026
Pharmaceutical
US AI leader Anthropic is expanding further into healthcare and drug development through a new four-year partnership with the Gates Foundation focused on vaccines, disease modeling and health-system operations in lower-income countries. 15 May 2026
Biotechnology
UK-based Isomorphic Labs, the AI-driven drug discovery company spun out of Google DeepMind, has raised $2.1 billion in a Series B financing round. 13 May 2026
Biotechnology
Privately-held Boston, USA, firm Cellular Intelligence has acquired global rights to Novo Nordisk's cell therapy program for Parkinson's disease. 12 May 2026
Pharmaceutical
British pharma major AstraZeneca is expanding its oncology-focused artificial intelligence collaboration with US biotech Immunai in a deal that could bring the smaller company up to $37.5 million over 2026-2027. 8 May 2026
Pharmaceutical
Ahead of a London event on May 12 on how AI is rapidly reshaping how healthcare information is discovered, interpreted and shared, this week's Expert View comes from panellist Sophie Randall, Director of the Patient Information Forum, the UK membership organization for people working in health information and support. 6 May 2026
Biotechnology
Profluent, the frontier AI company pioneering large-scale foundation models for protein design, today announced a multi-program strategic research collaboration with Eli Lilly to develop and commercialize custom site-specific recombinases to address diseases with severe unmet needs. 28 April 2026
Biotechnology
Belgian drugmaker UCB and the University of Southampton have announced a joint three-year project that they have dubbed the Digital Antibody Research Collaboration (DARC). 27 April 2026
Pharmaceutical
Merck & Co and Google Cloud have announced a landmark partnership to enhance the US pharma giant’s digital backbone as an AI-enabled enterprise. 23 April 2026
Biotechnology
This week on The Pharma Letter Podcast, we’re joined by Kenneth Mulvany, founder and executive chair of BenevolentAI: one of the UK’s earliest and most high-profile attempts to apply machine learning to drug discovery. 23 April 2026
Biotechnology
US biotech major Amgen has announced the retirement of David Reese, executive vice president and chief technology officer, effective June 30. 23 April 2026
Biotechnology
US biotech Elephas Biosciences has entered a research collaboration with artificial intelligence firm Mithrl, aiming to combine real-time tumor profiling with automated data analysis to better understand responses to immunotherapy. 17 April 2026
Pharmaceutical
Ryght AI, a provider of real-time generative AI solutions for the clinical research industry, has announced the launch of RyghtSites.com.
The free, publicly accessible tool allows pharmaceutical companies and Contract Research Organizations (CROs) to instantly search, rank, and download lists of the world's best clinical research sites for your search. 17 April 2026
Biotechnology
German innovation hub BioMed X has launched its first research team in France, partnering with French pharma Servier to advance AI-driven antibody engineering at the Paris-Saclay campus. 16 April 2026
Pharmaceutical
Novo Nordisk has announced a strategic partnership with OpenAI, the US AI research and deployment company. 14 April 2026
Biotechnology
Japanese drugmaker Daiichi Sankyo is deepening its push into AI-driven oncology, partnering with USA-based Imagene AI to advance biomarker discovery and response prediction across its cancer pipeline. 10 April 2026
Pharmaceutical
Tempus AI , a technology company leading the adoption of AI to advance precision medicine, has announced an expanded, multi-year collaboration with Gilead Sciences aimed at building and advancing Gilead’s oncology pipeline. 10 April 2026
Biotechnology
Syneron Bio, a China based leader in intelligent platform-driven macrocyclic peptide drug discovery, announced the successful closing of its Series B financing on March 31. The news comes less than four months after Syneron closed its Series A and A+ rounds at close to $100 million in total. 7 April 2026
Biotechnology
French biotech company Transgene , which develops virus-based immunotherapies for the treatment of cancer, and NEC Bio, a wholly owned subsidiary of NEC Corporation, a leader in IT, network and AI technologies, have signed a license agreement to advance the clinical development of TG4050, an individualized neoantigen therapeutic vaccine (INTV) in the adjuvant treatment of resected HPV-negative head and neck cancer. s 3 April 2026
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2026
| Headless Content Management with Blaze